skip to Main Content

Cohort Study of Pioglitazone and Bladder Cancer in Patients with Diabetes

This cohort study examines the possible association of pioglitazone use with the incidence of new bladder cancer in the Kaiser Permanente Northern California Diabetes Registry .

Investigator: Ferrara, Assiamira

Funder: Takeda Pharmaceuticals North America

Explore all studies and publications

Back To Top